Pfizer (PFE) is in talks to acquire rival Wyeth (WYE) in a deal that could be worth over $60B....


Pfizer (PFE) is in talks to acquire rival Wyeth (WYE) in a deal that could be worth over $60B. An acquisition would create a drug giant with combined revenue of around $75B and a strong line of blockbuster drugs. Sources say a deal is not yet imminent.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs